عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

Italy's Catania Airport Closed by Etna Volcanic Ash

The Mount Etna volcano spews lava during an eruption in Sicily island, Italy, 15 July 2024 (issued 16 July 2024). EPA/ORIETTA SCARDINO
The Mount Etna volcano spews lava during an eruption in Sicily island, Italy, 15 July 2024 (issued 16 July 2024). EPA/ORIETTA SCARDINO
TT
TT

Italy's Catania Airport Closed by Etna Volcanic Ash

The Mount Etna volcano spews lava during an eruption in Sicily island, Italy, 15 July 2024 (issued 16 July 2024). EPA/ORIETTA SCARDINO
The Mount Etna volcano spews lava during an eruption in Sicily island, Italy, 15 July 2024 (issued 16 July 2024). EPA/ORIETTA SCARDINO

Flights serving the eastern Sicilian city of Catania were halted on Tuesday after an eruption from nearby Mount Etna, the airport operator said, bringing fresh travel woe during the peak summer tourist season.
Etna, one of the world's most active volcanoes, has seen intense activity in recent days, spewing hot ash and lava, Reuters reported.
The airport of Catania had already been closed earlier this month due to ash in the sky. It acts as a hub for the east of Sicily and attracts more arrivals than the capital Palermo.
The statement said that authorities had decided on "the suspension of all incoming and outgoing flights."
"The suspension will result in cancellations and/or rerouting to other airports," it added, saying normal operations would resume once the ash fallout had ended.

Most Viewed

 
 
Varieties

King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
TT
TT

King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA

Saudi Arabia’s King Fahd Medical City and Boston Oncology have signed a Memorandum of Understanding (MoU) for a project to localize gene and target cell therapy.

The project will be held at King Fahd Medical City, one of the components of the Riyadh Second Health Cluster, the Saudi Press Agency (SPA) reported Monday.
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj.

The Saudi Deputy Minister for Planning and Development Eng. Abdulaziz Al-Rumaih attended the signing ceremony at the Saudi Ministry of Health.

AlGhofaili affirmed that the MoU aligns with the Medical City's plans towards the objectives of the Saudi Transformation Program in Healthcare Sector, which contributes to the enhancement of advanced healthcare services provided through the localization of modern techniques in treatment.

"The localization of therapeutic technology in the Kingdom is one of our main goals, which aligns with the Saudi Vision 2030 regarding health transformation programs,” SPA quoted AlGhofaili as saying.

“Therefore, we seek to develop local capabilities in the field of advanced medical treatment and technologies by enhancing cooperation with national and international institutions,” he added.